Published in BMC Endocr Disord on July 10, 2014
The Role of Supplemental Complex Dietary Carbohydrates and Gut Microbiota in Promoting Cardiometabolic and Immunological Health in Obesity: Lessons from Healthy Non-Obese Individuals. Front Nutr (2017) 0.75
Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial. PLoS One (2017) 0.75
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc (2003) 47.83
The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A (2004) 26.56
Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12
The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol (2009) 13.87
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A (2007) 9.71
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care (2000) 9.10
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature (2009) 8.71
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut (2009) 6.50
Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One (2010) 6.48
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A (2013) 5.88
Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia (2007) 5.61
High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology (2009) 5.08
A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr (2007) 4.34
PCR detection and quantitation of predominant anaerobic bacteria in human and animal fecal samples. Appl Environ Microbiol (1996) 4.10
Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab (2006) 3.84
Diet, gut microbiota and immune responses. Nat Immunol (2011) 3.66
Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol (2002) 3.35
Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes (2009) 3.17
Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut (2012) 3.09
Effects of short chain fatty acids on gut morphology and function. Gut (1994) 2.92
Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr (2008) 2.69
High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One (2010) 2.60
Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med (2011) 2.59
Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol (2011) 2.44
Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc (2004) 2.28
Regulation of inflammation by short chain fatty acids. Nutrients (2011) 2.15
Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol (2011) 2.03
Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol (2010) 1.92
Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr (2009) 1.90
Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes (2006) 1.83
Diabetes and advanced glycoxidation end products. Diabetes Care (2006) 1.75
RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J Am Soc Nephrol (2009) 1.72
Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr (2011) 1.72
The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia (2010) 1.67
Targeted reduction of advanced glycation improves renal function in obesity. Kidney Int (2011) 1.63
Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol (2011) 1.55
Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema. Diabetologia (2004) 1.53
Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev (2010) 1.53
Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol (2005) 1.43
Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One (2010) 1.43
Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care (2011) 1.41
Dicarbonyl intermediates in the maillard reaction. Ann N Y Acad Sci (2005) 1.41
Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci (2005) 1.40
Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. Diabetes (2005) 1.39
A double-blind placebo-controlled study to establish the bifidogenic dose of inulin in healthy humans. Eur J Clin Nutr (2007) 1.38
Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc Natl Acad Sci U S A (2012) 1.38
The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev (2011) 1.37
Intestinal flora and endogenous vitamin synthesis. Eur J Cancer Prev (1997) 1.33
Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. J Nutr Biochem (2010) 1.30
Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr (2006) 1.30
A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am J Clin Nutr (2010) 1.28
Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr (2007) 1.25
Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients. Clin Chem Lab Med (2005) 1.23
Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm Bowel Dis (2010) 1.22
Advanced glycation end products are direct modulators of β-cell function. Diabetes (2011) 1.14
Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunol Rev (2012) 1.13
Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics). Aging Cell (2011) 1.12
The effects of the Maillard reaction on the physical properties and cell interactions of collagen. Pathol Biol (Paris) (2006) 1.10
Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance? Curr Opin Clin Nutr Metab Care (2011) 1.07
Protein glycation: creation of catalytic sites for free radical generation. Ann N Y Acad Sci (2001) 1.05
Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects. Cardiovasc Ther (2010) 1.04
Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance. Eur J Clin Nutr (2006) 1.03
Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic review. Eur J Clin Nutr (2013) 1.03
Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults. J Am Geriatr Soc (2009) 1.03
Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr (2012) 1.02
Projecting the burden of diabetes in Australia--what is the size of the matter? Aust N Z J Public Health (2009) 1.02
Attenuation of colonic inflammation by PPARgamma in intestinal epithelial cells: effect on Toll-like receptor pathway. Dig Dis Sci (2006) 1.02
Arabinoxylan fibre improves metabolic control in people with Type II diabetes. Eur J Clin Nutr (2004) 1.01
Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women. Diabetes Care (2013) 1.00
Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. Diabetes Care (2007) 1.00
Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foods. Amino Acids (2005) 1.00
Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E. Diabetologia (2011) 0.99
The food additives inulin and stevioside counteract oxidative stress. Int J Food Sci Nutr (2010) 0.98
Effect of short-term intralipid infusion on the immune response during low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab (2007) 0.98
Serum advanced glycation end products (AGEs) are associated with insulin resistance. Diabetes Metab Res Rev (2011) 0.96
Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue. Clin Microbiol Infect (2012) 0.96
Metabolic diseases and pro- and prebiotics: Mechanistic insights. Nutr Metab (Lond) (2012) 0.94
Probiotics, prebiotics, and synbiotics: gut and beyond. Gastroenterol Res Pract (2012) 0.94
Propionate lowers blood glucose and alters lipid metabolism in healthy subjects. Am J Clin Nutr (1991) 0.93
Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians. Mol Nutr Food Res (2006) 0.92
Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults. J Nutr (2011) 0.91
Factors related to colonic fermentation of nondigestible carbohydrates of a previous evening meal increase tissue glucose uptake and moderate glucose-associated inflammation. Am J Clin Nutr (2009) 0.91
Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics. Amino Acids (2010) 0.90
Advanced glycation end product homeostasis: exogenous oxidants and innate defenses. Ann N Y Acad Sci (2008) 0.89
Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies. Gastroenterol Clin North Am (2011) 0.89
Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women. Atherosclerosis (2009) 0.88
Health effects of dietary Maillard reaction products: the results of ICARE and other studies. Amino Acids (2010) 0.87
Inhibition of lipid peroxidation by Lactobacillus acidophilus and Bifidobacterium longum. J Agric Food Chem (1999) 0.87
Effects of konjac glucomannan on putative risk factors for colon carcinogenesis in rats fed a high-fat diet. J Agric Food Chem (2011) 0.87
The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health? Mol Nutr Food Res (2010) 0.86
Metabolic transit and in vivo effects of melanoidins and precursor compounds deriving from the Maillard reaction. Ann Nutr Metab (2001) 0.86
Advanced glycation end products-induced reactive oxygen species generation is partly through NF-kappa B activation in human aortic endothelial cells. J Diabetes Complications (2012) 0.85
Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults. Ann Nutr Metab (2009) 0.85
Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine. Clinics (Sao Paulo) (2010) 0.85
Dietary protein-induced increases in urinary calcium are accompanied by similar increases in urinary nitrogen and urinary urea: a controlled clinical trial. J Acad Nutr Diet (2013) 0.85
A comparative in vitro investigation into the effects of cooked meats on the human faecal microbiota. Anaerobe (2010) 0.84
A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med (2003) 7.74
A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet (2011) 5.61
Retracted Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. JAMA (2013) 4.88
Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes (2008) 4.13
2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol (2012) 3.15
Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes (2007) 2.51
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes (2008) 2.41
Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol (2013) 2.28
'Reverse white-coat hypertension' in older hypertensives. J Hypertens (2002) 2.17
Rate of morning increase in blood pressure is elevated in hypertensives. Am J Hypertens (2006) 2.15
Diabetes detection in Australian general practice: a comparison of diagnostic criteria. Med J Aust (2002) 2.14
Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension (2007) 2.13
miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes (2010) 1.95
Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives. Hypertension (2006) 1.90
Retracted Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial. Ann Intern Med (2006) 1.71
Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality. Ann Thorac Surg (2009) 1.69
Targeted reduction of advanced glycation improves renal function in obesity. Kidney Int (2011) 1.63
Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery? JACC Cardiovasc Interv (2009) 1.61
Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy. Kidney Int (2010) 1.57
Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents. Catheter Cardiovasc Interv (2009) 1.51
Increased iodine deficiency in Victoria, Australia: analysis of neonatal thyroid-stimulating hormone data, 2001 to 2006. Med J Aust (2010) 1.50
Factors associated with deep sternal wound infection and haemorrhage following cardiac surgery in Victoria. Interact Cardiovasc Thorac Surg (2006) 1.48
Should aspirin be used for the primary prevention of cardiovascular disease in people with diabetes? Med J Aust (2009) 1.45
Progress towards a National Cardiac Procedure Database--development of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne Interventional Group (MIG) registries. Heart Lung Circ (2010) 1.44
Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men Study. J Vasc Surg (2009) 1.41
Ten-year legacy effects of baseline blood pressure 'treatment naivety' in the Second Australian National Blood Pressure study. J Hypertens (2015) 1.41
Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens (2005) 1.40
Amino-terminal-pro-B-type natriuretic peptide levels and low diastolic blood pressure: potential relevance to the diastolic J-curve. J Hypertens (2014) 1.39
Recent trends in Australian percutaneous coronary intervention practice: insights from the Melbourne Interventional Group registry. Med J Aust (2011) 1.38
Validated Assessment Tools and Maintenance of Certification in Plastic Surgery: Current Status, Challenges, and Future Possibilities. Plast Reconstr Surg (2016) 1.37
Comparing trends in BMI and waist circumference. Obesity (Silver Spring) (2010) 1.26
Trends in BMI of urban Australian adults, 1980-2000. Public Health Nutr (2009) 1.18
Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Med J Aust (2006) 1.16
Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry. JACC Cardiovasc Interv (2010) 1.14
Interactions between renin angiotensin system and advanced glycation in the kidney. J Am Soc Nephrol (2005) 1.14
Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase. J Hypertens (2010) 1.12
Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients). Am J Cardiol (2011) 1.07
Smaller aortic dimensions do not fully account for the greater pulse pressure in elderly female hypertensives. Hypertension (2008) 1.05
Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis. J Hypertens (2009) 1.02
Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes. Free Radic Biol Med (2011) 0.99
Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. Am J Physiol Renal Physiol (2009) 0.96
Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention. Am J Cardiol (2011) 0.95
The heart of the matter: health status of aged care clients receiving home- and community-based care. J Aging Res (2010) 0.93
Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. Am J Physiol Endocrinol Metab (2008) 0.92
Validity of self-reported hypertension: findings from the Thai Cohort Study compared to physician telephone interview. Glob J Health Sci (2013) 0.92
Sex differences in outcomes following isolated coronary artery bypass graft surgery in Australian patients: analysis of the Australasian Society of Cardiac and Thoracic Surgeons cardiac surgery database. Eur J Cardiothorac Surg (2011) 0.92
Trends in coronary artery bypass graft surgery in Victoria, 2001-2006: findings from the Australasian Society of Cardiac and Thoracic Surgeons database project. Med J Aust (2008) 0.91
Ankle-Brachial Index determination and peripheral arterial disease diagnosis by an oscillometric blood pressure device in primary care: validation and diagnostic accuracy study. BMJ Open (2012) 0.90
Advanced glycation end products augment experimental hepatic fibrosis. J Gastroenterol Hepatol (2013) 0.89
Large artery stiffness is not related to plasma cholesterol in older subjects with hypertension. Arterioscler Thromb Vasc Biol (2004) 0.88
Critical analysis of early and late outcomes after isolated coronary artery bypass surgery in elderly patients. Ann Thorac Surg (2011) 0.88
Health risk factors and the incidence of hypertension: 4-year prospective findings from a national cohort of 60 569 Thai Open University students. BMJ Open (2013) 0.87
Prevalence of underweight, overweight and obesity in urban Hanoi, Vietnam. Asia Pac J Clin Nutr (2009) 0.87
Impact of prosthesis--patient mismatch after mitral valve replacement: a multicentre analysis of early outcomes and mid-term survival. Heart (2011) 0.86
The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis. J Rheumatol (2009) 0.85
Overview of pharmacoeconomic modelling methods. Br J Clin Pharmacol (2013) 0.84
Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes. Int J Cardiol (2010) 0.84
Health-risk factors and the prevalence of hypertension: cross-sectional findings from a national cohort of 87,143 Thai Open University students. Glob J Health Sci (2013) 0.84
Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse. Diabetes (2010) 0.83
Postoperative atrial fibrillation after isolated aortic valve replacement: a cause for concern? Ann Thorac Surg (2012) 0.83
Advanced glycation end products as environmental risk factors for the development of type 1 diabetes. Curr Drug Targets (2012) 0.83
Impact of left ventricular dysfunction on early and late outcomes in patients undergoing concomitant aortic valve replacement and coronary artery bypass graft surgery. Cardiol J (2013) 0.82
Funding linked to ongoing research: impact of the bosentan patient registry on pricing in Australia. Value Health (2011) 0.82
Urinary iodine deficiency in Gippsland pregnant women: the failure of bread fortification? Med J Aust (2011) 0.82
Targeting the AGE-RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end-product content. Nephrology (Carlton) (2013) 0.82
Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients. J Hypertens (2014) 0.82
An Australian risk prediction model for determining early mortality following aortic valve replacement. Eur J Cardiothorac Surg (2011) 0.82
Glucose homeostasis can be differentially modulated by varying individual components of a western diet. J Nutr Biochem (2013) 0.82
Early and late outcomes after isolated aortic valve replacement in octogenarians: an Australasian Society of Cardiac and Thoracic Surgeons Cardiac Surgery Database Study. Eur J Cardiothorac Surg (2012) 0.81
The economic implications of treating atherothrombotic disease in Australia, from the government perspective. Clin Ther (2010) 0.81
Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registry. Med J Aust (2008) 0.81
Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms. Eur J Prev Cardiol (2012) 0.81
Smoking and primary total hip or knee replacement due to osteoarthritis in 54,288 elderly men and women. BMC Musculoskelet Disord (2013) 0.81
Nonsymmetrical double logistic analysis of ambulatory blood pressure recordings. J Appl Physiol (1985) (2004) 0.81
Quality control activities associated with registries in interventional cardiology and surgery. Heart Lung Circ (2011) 0.80
Prediction of cardiovascular events in subjects in the second Australian National Blood Pressure study. Hypertension (2010) 0.80
Does patient gender affect outcomes after concomitant coronary artery bypass graft and aortic valve replacement? An Australian Society of Cardiac and Thoracic Surgeons Database study. Cardiology (2011) 0.80
Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects. Amino Acids (2013) 0.80
Is it cost-effective to increase aspirin use in outpatient settings for primary or secondary prevention? Simulation data from the REACH Registry Australian Cohort. Cardiovasc Ther (2011) 0.80
N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF). Eur J Heart Fail (2013) 0.80
Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry). Am J Cardiol (2008) 0.80
Predictors of poor glycaemic control during the initial five years post-diagnosis in rural adults with type 2 diabetes. Aust J Rural Health (2011) 0.80
Cardiovascular disease in Australia: calm before a new storm? Clin Exp Pharmacol Physiol (2013) 0.80
Deficiency in mitochondrial complex I activity due to Ndufs6 gene trap insertion induces renal disease. Antioxid Redox Signal (2013) 0.79
Short- and long-term survival in treated elderly hypertensive patients with or without diabetes: findings from the Second Australian National Blood Pressure study. Am J Hypertens (2013) 0.79
NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF). Int J Cardiol (2013) 0.79
A score for the prediction of cardiovascular events in the hypertensive aged. Am J Hypertens (2011) 0.79
Health knowledge and iodine intake in pregnancy. Aust N Z J Obstet Gynaecol (2014) 0.79
The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-year follow-up data from the Australian REACH registry. Cardiovasc Ther (2013) 0.78
Review on cardiovascular risk prediction. Cardiovasc Ther (2015) 0.78
A propensity-score matched analysis on the impact of postoperative atrial fibrillation on the early and late outcomes after concomitant aortic valve replacement and coronary artery bypass graft surgery. J Cardiovasc Med (Hagerstown) (2014) 0.78
Examining the signs and symptoms experienced by individuals with suspected acute coronary syndrome in the Asia-Pacific region: a prospective observational study. Ann Emerg Med (2012) 0.78
Cardiovascular medication use following percutaneous coronary intervention: the Australian experience. Cardiovasc Ther (2014) 0.77
Predicting the effectiveness of prevention: a role for epidemiological modeling. J Prim Prev (2008) 0.77
Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention. Am J Cardiol (2011) 0.77
Cardio classics revisited: focus on the role of amlodipine. Integr Blood Press Control (2012) 0.77
Predictors of annual pharmaceutical costs in Australia for community-based individuals with, or at risk of, cardiovascular disease: analysis of Australian data from the REACH registry. Am J Cardiovasc Drugs (2010) 0.77